Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications

Autor: M. Reth, E W N Levarht, Hans Scherer, J.C. Kwekkeboom, J. W. Drijfhout, Holger Bang, Sanne Reijm, Gerrie Stoeken-Rijsbergen, Arieke S. B. Kampstra, George M.C. Janssen, P.A. van Veelen, Marco Cavallari, Corrie M. Wortel, Rem Toes, Twj Huizinga, Theresa Kissel, Rochelle D Vergroesen, Kimberly M. Bonger, Linda M. Slot
Přispěvatelé: Academic Medical Center
Rok vydání: 2020
Předmět:
Male
rheumatoid arthritis
0301 basic medicine
autoantibodies
medicine.drug_class
Immunology
Receptors
Antigen
B-Cell

Synthetic Organic Chemistry
Cross Reactions
medicine.disease_cause
Monoclonal antibody
Cross-reactivity
Anti-Citrullinated Protein Antibodies
General Biochemistry
Genetics and Molecular Biology

Arthritis
Rheumatoid

03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Rheumatology
Antigen
medicine
Humans
Immunology and Allergy
Receptor
Aged
030203 arthritis & rheumatology
B-Lymphocytes
B cells
Protein Carbamylation
biology
business.industry
Autoantibody
Acetylation
Middle Aged
3. Good health
Cell biology
030104 developmental biology
chemistry
Immunoglobulin G
Acetyllysine
Monoclonal
biology.protein
Citrulline
Citrullination
Female
Antibody
business
Protein Processing
Post-Translational
Zdroj: Annals of the rheumatic diseases, 79(4):216499, 472-480. BMJ Publishing Group
Annals of the Rheumatic Diseases, 79, 472-480
Annals of the Rheumatic Diseases, 79, 4, pp. 472-480
Annals of the Rheumatic Diseases, 79(4), 472-480. BMJ PUBLISHING GROUP
Annals of the rheumatic disease
ISSN: 1468-2060
0003-4967
Popis: ObjectiveAutoantibodies against antigens carrying distinct post-translational modifications (PTMs), such as citrulline, homocitrulline or acetyllysine, are hallmarks of rheumatoid arthritis (RA). The relation between these anti-modified protein antibody (AMPA)-classes is poorly understood as is the ability of different PTM-antigens to activate B-cell receptors (BCRs) directed against citrullinated proteins (CP). Insights into the nature of PTMs able to activate such B cells are pivotal to understand the ‘evolution’ of the autoimmune response conceivable underlying the disease. Here, we investigated the cross-reactivity of monoclonal AMPA and the ability of different types of PTM-antigens to activate CP-reactive BCRs.MethodsBCR sequences from B cells isolated using citrullinated or acetylated antigens were used to produce monoclonal antibodies (mAb) followed by a detailed analysis of their cross-reactivity towards PTM-antigens. Ramos B-cell transfectants expressing CP-reactive IgG BCRs were generated and their activation on stimulation with PTM-antigens investigated.ResultsMost mAbs were highly cross-reactive towards multiple PTMs, while no reactivity was observed to the unmodified controls. B cells carrying CP-reactive BCRs showed activation on stimulation with various types of PTM-antigens.ConclusionsOur study illustrates that AMPA exhibit a high cross-reactivity towards at least two PTMs indicating that their recognition pattern is not confined to one type of modification. Furthermore, our data show that CP-reactive B cells are not only activated by citrullinated, but also by carbamylated and/or acetylated antigens. These data are vital for the understanding of the breach of B-cell tolerance against PTM-antigens and the possible contribution of these antigens to RA-pathogenesis.
Databáze: OpenAIRE